Resources by service
A New Resupply Strategy Turns an Emergency into an Opportunity
A customer faced with impending comparator shortage, complicated by expanding enrollment, partners with Almac’s Supply Chain Managers (SCM) to evaluate supply chain needs, assess potential risks, stretch supply and advise on global and regional clinical strategy.
When Almac Clinical Services was called in to address an impending product expiry, the sponsor’s situation with a Phase II clinical trial was quite precarious. The clinical trial was comparing the safety and efficacy of the sponsor’s Investigational Medicinal Product (IMP) to a comparator product at 74 sites across 13 countries. The comparator product was difficult to procure, and 100 percent of existing supplies were due to expire in 2 months.
Almac Clinical Services immediately set about estimating how much of the comparator product would be needed and how the limited supplies should effectively be distributed. The goal was to minimise interruption to the study by acting swiftly and on the basis of facts.
Thanks to Almac’s intervention, the sponsor’s clinical operations team’s fears were avoided. There was no need to halt enrolment. By carefully apportioning existing supplies according to Almac’s plan, the sponsor was able to continue the clinical trial uninterrupted; continuity that was important in preserving the sponsor’s relationships with sites and to keeping the development timeline on track avoiding additional costs and delays.
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to email@example.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.